ACTUAL PROBLEMS OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES

Abstract

The incidence of type 2 diabetes is rapidly increasing. Diabetic vascular complications accordingly increase as well. The development of complications is due not only to phenotypic but to genotypic factors as well. It is important to promptly identify genotypic changes and their relationship with adjustable risk factors for type 2 diabetes complications such as diubelic nephropathy.

Keywords:

diabetes mellitus, diabetic nephropathy.

References

1. http://www. who- int/diabetes /facts /world_figures/en/.

2. Реальное бремя диабета IDF Diabetes Atlas (4-thedition), 2009: 27

3. WHO Global Into Base (htpp vww. infobase.who.int.)

4. Kramer W New approaches to the treatment of diabetes. Exp Clin Endocrinol Diabetes 1999, 107 (Sappl.2): S52-S61.

5. Майоров А.Ю., Урбанова К.A , Галстян Г Р Методы количественной оценки инсулинорезистентности.//Ожирение и метаболизм 2009, №2.-С. 19.

6. Bloomgarden / Т. Developments in diabetes and insulin resistance // Diabetes Care. - 2006; 26: 161-167.

7. Resolution of the Sixty-first World Health Assembly 2008: Prevention and Control of Noncommunicable Diseases: Implementation of the Global Strategy/World Health Assembly resolution WHA61 14 (May 2008)

8. Global Strategy for the Prevention and Control of Noncommunicable Diseases/World Health Assembly document A53/14 (March 2000)

9. Resolution of the Fifty-third World Health Assembly 2000: Prevention and Control of Noncommunicable Diseases/World Health Assembly resolution W HA53.17 (May 2000)

10. Бокарев И М., Великов В.К , Шубина О И. Сахарный диабет: Руководство для врачей.- М : ООО « Медицинское информационное агентство», 2006 - 400с : ил.,

11. Клиническое руководство по диагностике и лечению сахарного диабета 2 типа на первичном уровне здравоохранения / Под общим руководством и ред. М.С. Молдобаевой —Бишкек, 2010.-90 с

12. L.Ryden,E Standi, М Bartnik, G Van den Berghe, Betteridge, M.J de Boer et all Guidelines on diabetes, pre-diabetes and cardiovascular diseases EurHeartJ 2007, doi: 10 1093/eurheartj/ehl261.

13. Campbell I W Need for intensive, early glycaemic control in patients with type 2 diabetes // Br J Cardiol. 2000: 7(10): 625-631.

14. The Action to Control Cardiovascular Risk m Diabetes Studt Group: Effectsof intensive glucose levering in type 2 diabetes // N Engl J Med. 2008; 358: 2545-2559.

15. The ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes // N Engl J Med. 2008; 2560-2572.

16. Дедов И И , Лебедев Н.Б., Сунцов Ю.И. Проблемы эндокринологии, 1996, (5):3-7.

17. Masato Fujisawa, Yasuji Ichikawa, KunihikoYoshiya, and others, Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey Urology - August 2000 (Vol. 56, Issue 2. Pages 201- 206)

18. Disney A. PS., Puss G R , Walker R , Shell A.G.R. eds. Australia and New Zealand Dialysis andTransplant Registry (ANZDATA) (1998). Adelaide, South Anzdata: Australia; 1998

19. NelsonR.G., MorgensternH., BennetPH.,1998.

20. Earle К A , Mehrotra S , Dalton R.N. et al. Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with white origin. J. Am Soc. Nephrol. 2001; 12: 2125-2130.

21. Earle К A Porter K.K.; Ostberg S. et al. Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial. Transplant. 2001; 16: 286-290.

22. Chan J.C.N., Wat N.M.S., So W.-Y. et al. Remm angiotensin aldosterone system blockade and renal disease in patient with type 2 diabetes. Diabetes Care 2004; 27 874-879

23. М. И. Балаболкин., E М. Клебанова., B.M. Креминская. Лечение сахарного диабета и его осложнений: Учебн. пособие. - М.: ОАО Издательство «Медицина», 2005. - 512с: ил. (Учеб. лит. для слушателей системы последипломного образования)

24. Geoffrey VG Non —insulin - dependent diabetes mellitus. Ineds PickupJ.C., WilliamsG. Textbookofdiabetes. Oxford: Blackwell Scientific Publications; 1991, 24-29

25. Дедов И И , Шестакова MB. Диабетическая нефропатия — М.: «Универсум Паблишинг», 2000.

26. Ю С Астахов, Ф.Е Шадричев, Г.Р. Галстян, Л.А. Чуфгунова, М. В.Шестакова, М.Ш., Шамхалова Рациональная фармакотерапия заболеваний эндокринной системы и нарушений обмена веществ: Руководство для практикующих врачей. - М.: ООО «Эббот Продактс». 2011 - 40с.: ил.;

Published

2024-11-19

How to Cite

Молдобаева, М., and Д. Исабаева. “ACTUAL PROBLEMS OF DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES ”. Euroasian Health Journal, vol. 1, no. 1, Nov. 2024, pp. 128-34, https://vestnik.kgma.kg/index.php/vestnik/article/view/1798.

Issue

Section

REVIEW ARTICLES